1/31
Vocabulary practice flashcards focusing on Mendelian genetics, multiple allelism in AB0 blood groups, molecular mechanisms of dominance and recessiveness, penetrance, expressivity, and X-linked neuromuscular disorders.
AB0 Blood Group System
A human blood group system determined by three multiple alleles of the same gene (IA, IB, and i) resulting in six possible genotypes and four distinct phenotypes (A, B, AB, and 0).
Codominance
A genetic relationship in which both alleles are simultaneously and fully expressed in the heterozygote without one masking the other, producing a 1:2:1 phenotypic ratio in a monohybrid cross of two heterozygotes (e.g., the IAIB genotype expressing both A and B antigens).
Complete Dominance
A mode of inheritance where the dominant allele completely masks the recessive allele in heterozygotes, resulting in a 3:1 phenotypic ratio and a 1:2:1 genotypic ratio from a cross between two heterozygotes (Aa×Aa).
Incomplete Dominance
An inheritance pattern in which the heterozygous individual manifests an intermediate phenotype between the two homozygotes, yielding a 1:2:1 phenotypic ratio (e.g., pink flowers resulting from red and white flowering plants).
Universal Donor (AB0)
An individual belonging to blood group 0 who possesses neither A nor B surface antigens on their red blood cells and can donate red blood cells to all AB0 blood groups.
Universal Recipient (AB0)
An individual with blood group AB whose plasma contains neither anti-A nor anti-B antibodies, allowing them to receive red blood cells from groups A, B, AB, and 0 in the AB0 system.
Sickle Cell Anemia
An inherited autosomal recessive disease caused by a variant in the HBB gene encoding beta-globin, producing hemoglobin S (HbS) that polymerizes under deoxygenated conditions and deforms red blood cells into a sickle shape.
Sickle Cell Trait
The heterozygous state (HbA/HbS) in which an individual produces both normal hemoglobin A and hemoglobin S; such individuals generally do not exhibit sickle cell anemia but may experience complications under severe hypoxia or dehydration.
Beta-Thalassemia
A group of hereditary disorders resulting from variants in the HBB gene that decrease or completely prevent the production of beta-globin chains in hemoglobin.
Compound Heterozygote
An individual who carries two distinct pathogenic variants within the same gene, one on each homologous chromosome, which can cause clinical manifestation of an autosomal recessive condition.
Autosomal Recessive Inheritance
A transmission pattern where a genetic disorder typically manifests only when both copies of an autosomal gene harbor pathogenic variants, frequently operating via a loss-of-function molecular mechanism.
Autosomal Dominant Inheritance
A mode of inheritance in which the presence of a single pathogenic allele on an autosome is sufficient to manifest the disease phenotype in heterozygotes, often characterized by vertical transmission across generations.
De Novo Mutation
A new genetic alteration arising spontaneously in a germ cell or during early embryonic development, resulting in a dominant disorder appearing in an individual with unaffected parents.
Gain of Function
A dominant pathogenic mechanism whereby a mutated protein acquires a novel activity or exhibits excessive, constitutive, or dysregulated normal activity (e.g., FGFR3 in achondroplasia, HTT in Huntington chorea, and oncogenes).
Dominant Negative Effect
A molecular mechanism where a mutant protein actively interferes with the function or structural assembly of the normal protein produced by the wild-type allele (e.g., fibrillin-1 encoded by FBN1 in Marfan syndrome).
Haploinsufficiency
A condition in dominant disorders where a single functional copy of a gene produces an insufficient amount of protein (approximately 50% of normal levels) to preserve a wild-type phenotype (e.g., Waardenburg syndrome).
Penetrance
The proportion of individuals carrying a specific genotype who actually display the associated recognizable clinical phenotype.
Incomplete Penetrance
A genetic phenomenon in which some individuals who possess a pathogenic genotype fail to express the corresponding clinical phenotype.
Variable Expressivity
Variation in the degree, severity, symptoms, or specific organ manifestations of a genetic condition among individuals sharing the same pathogenic genotype (e.g., Marfan syndrome).
Thermolabile Tyrosinase
A temperature-sensitive enzyme variant in Siamese cats that loses catalytic activity at higher core body temperatures but retains function at cooler extremities, leading to localized melanin synthesis in ears, paws, snout, and tail.
Phenylketonuria (PKU)
An autosomal recessive inborn error of metabolism caused by variants impairing phenylalanine hydroxylase (PAH), leading to neurotoxic accumulation of phenylalanine that can be effectively managed with a low-phenylalanine diet.
Epigenetic Modifications
Heritable or stable regulatory mechanisms, such as DNA methylation and histone modifications, that modulate gene expression levels without altering the underlying nucleotide sequence of DNA.
CFTR
An ATP-regulated ABC transporter family protein acting as an epithelial ion channel for chloride and bicarbonate ions; pathogenic variants in its gene disrupt epithelial fluid balance, causing cystic fibrosis.
Genetic Heterogeneity
The biological occurrence where mutations in different, independent genes give rise to the same or very similar clinical phenotypes, as exemplified by various oculocutaneous forms of albinism.
Hemizygosity
The genetic state of possessing only a single copy of a gene or chromosome segment, which is normal for males (XY) regarding genes located on the X chromosome.
Morgan's Drosophila Experiment
Thomas Hunt Morgan's breeding crosses demonstrating X-linkage using white-eyed mutant fruit flies, revealing that all F1 offspring had red eyes while in the F2 generation the white-eye phenotype appeared exclusively in males.
Dystrophin
A structural protein localized to the inner surface of the sarcolemma that anchors the internal cytoskeleton to membrane protein complexes and the extracellular matrix, stabilizing muscle fibers during contraction.
Reading-Frame Rule
The molecular principle stating that out-of-frame variants in the DMD gene disrupt translation to yield no functional dystrophin (Duchenne), while in-frame variants permit the production of an internally shortened, partially functional protein (Becker).
Duchenne Muscular Dystrophy (DMD)
A severe X-linked recessive neuromuscular disease caused by DMD gene variants that completely abolish functional dystrophin, characterized by early childhood onset and rapid, progressive muscle degeneration.
Becker Muscular Dystrophy (BMD)
An X-linked recessive muscular dystrophy caused by DMD gene variants that result in a structurally altered or reduced quantity of dystrophin that retains partial function, leading to a later onset and slower progression than Duchenne.
Barr Body
The dense, condensed structure formed by the largely transcriptional inactivated X chromosome in female mammalian somatic cell nuclei.
Skewed X-Inactivation
A non-random pattern of X-chromosome inactivation where the normal X chromosome is silenced in an unusually high proportion of cells, potentially causing female carriers of X-linked recessive variants to present clinical symptoms.